Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
NAT2 encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Additionally we are shipping NAT2 Antibodies (1) and and many more products for this protein.
Showing 3 out of 6 products:
Slow NAT2 (show SLC38A1 ELISA Kits) acetylators demonstrated a significant association with risk of anti-tuberculosis drug-induced liver injury in Thai patients.
The present study demonstrated no association between NAT2 (show SLC38A1 ELISA Kits) genotype and drug-induced hepatotoxicity in the north Indian patients with tuberculosis.
CYP3A4 (show CYP3A4 ELISA Kits) expression and N-acetyl transferase 2 acetylator phenotype can better identify the patients with higher risk of adverse reactions and can facilitate the improvement of personalized clonazepam therapy and withdrawal regimen.
NAT2 (show SLC38A1 ELISA Kits) genotypes are associated with N-acetylation phenotype variation.
NAT2 (show SLC38A1 ELISA Kits) acetylator genotype has an important role in 4, 4'-methylene bis (show BAG3 ELISA Kits) (2-chloroaniline) metabolism and suggest that risk assessments related to 4, 4'-methylene bis (show BAG3 ELISA Kits) (2-chloroaniline) exposures consider accounting for NAT2 (show SLC38A1 ELISA Kits) acetylator phenotype in the analysis
Review/Meta-analysis: NAT2 (show SLC38A1 ELISA Kits) slow acetylation genotype is associated with an increased bladder cancer risk in Chinese individuals.
six selected NAT2 (show SLC38A1 ELISA Kits) exonic single nucleotide polymorphisms were genotyped in an independent case-control sample of a Northern Chinese Han population to verify the possible association between NAT2 (show SLC38A1 ELISA Kits) and schizophrenia. Three (rs1801280T/341C, rs1799930/G590A, and rs1208/A803G) of the six single nucleotide polymorphisms showed significant allele frequency differences between the case and the control groups.
Our findings suggested that NAT2 (show SLC38A1 ELISA Kits) gene polymorphism rs1799931 was associated with decreased risk of acute myeloid leukemia (show BCL11A ELISA Kits) and was likely to be a protective factor against acute myeloid leukemia (show BCL11A ELISA Kits) development.
Study reestablished the association between NAT2 (show SLC38A1 ELISA Kits) SA and isoniazid-induced liver injury in a Singaporean population and demonstrated its clinical validity in prediction of isoniazid-induced liver injury.
In non-syndromic cleft lip with or without cleft palate, we found a significant association between the EGF61 (rs4444903) and NSCL (show NHLH1 ELISA Kits)/P (P = .01) genes. Conversely, NAT2 (show SLC38A1 ELISA Kits) (rs1799929) was not significantly different between the cases and the control group
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2).
N-acetyltransferase type 2
, arylamide acetylase 2
, arylamine N-acetyltransferase 2